Showing 341 - 360 results of 1,132 for search '"immunosuppression"', query time: 0.06s Refine Results
  1. 341

    Giant Condyloma Acuminatum of Vulva in an HIV-Infected Woman by Athanase Lilungulu, Bonaventura C. T. Mpondo, Abdallah Mlwati, Dismas Matovelo, Albert Kihunrwa, Balthazar Gumodoka

    Published 2017-01-01
    “…The most common risk factor is immunosuppression with HIV; however, any other cause of immunodeficiency can be a predisposing factor. …”
    Get full text
    Article
  2. 342

    Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation by Dawei Yang, Jennifer M Wilson, Chunxue Bai, John Yee, Pearce G Wilcox, Nasreen Khalil, Robert D Levy

    Published 2012-01-01
    “…Following single lung transplantation, patients receive maintenance immunosuppression, which could mitigate the development of acute exacerbations in the native lung. …”
    Get full text
    Article
  3. 343

    Potentially paraneoplastic glomerulopathies in a Brazilian cohort: a retrospective analysis by Marcella Soares Laferreira, Gianna Mastroianni Kirsztajn

    Published 2025-01-01
    “…The dose of the immunosuppressive agents among patients with neoplasms before or after immunosuppression was not statistically different. …”
    Get full text
    Article
  4. 344

    Macrophages in Tumor Microenvironments and the Progression of Tumors by Ning-Bo Hao, Mu-Han Lü, Ya-Han Fan, Ya-Ling Cao, Zhi-Ren Zhang, Shi-Ming Yang

    Published 2012-01-01
    “…In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. …”
    Get full text
    Article
  5. 345

    Skin Abscess due to Serratia marcescens in an Immunocompetent Patient after Receiving a Tattoo by J. Diranzo García, J. Villodre Jiménez, V. Zarzuela Sánchez, L. Castillo Ruiperez, A. Bru Pomer

    Published 2015-01-01
    “…To our knowledge, this is the first reported case of a S. marcescens skin infection following a tattoo, in the absence of immunosuppression.…”
    Get full text
    Article
  6. 346

    Collecting Duct Carcinoma of the Native Kidney in a Renal Transplant Recipient by Ian Zheng, Mahmoud Alameddine, Yaohong Tan, Zhobin Moghadamyeghaneh, Joshua S. Jue, Ali Yusufali, Ahmed Farag, Gaetano Ciancio

    Published 2017-01-01
    “…To our knowledge, CDC in the setting of renal transplant and long-term immunosuppression has not been previously described.…”
    Get full text
    Article
  7. 347

    Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin by Samir J. Patel, Samantha A. Kuten, Richard J. Knight, Dana M. Hong, A. Osama Gaber

    Published 2014-01-01
    “…Management of ganciclovir-resistant CMV may be complicated by nephrotoxicity which is commonly observed with recommended therapies and/or rejection induced by “indirect” viral effects or reduction of immunosuppression. Herein, we report a series of four high serologic risk (donor CMV positive/recipient CMV negative) kidney transplant patients diagnosed with ganciclovir-resistant CMV disease. …”
    Get full text
    Article
  8. 348

    Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation by Ravi Starzl, Gerald Brandacher, W. P. Andrew Lee, Jaime Carbonell, Wensheng Zhang, Jonas Schnider, Vijay Gorantla, Stefan Schneeberger, Xin Xiao Zheng

    Published 2013-01-01
    “…Many of the challenges that have historically been limiting factors in transplantation, such as rejection and the morbidity of immunosuppression, remain challenges in VCA. Because of the accessibility of most VCA grafts, and the highly immunogenic nature of the skin in particular, VCA has become the focal point for cross-disciplinary approaches to developing novel approaches for some of the most challenging immunological problems in transplantation, particularly the early diagnoses and assessment of rejection. …”
    Get full text
    Article
  9. 349

    Innovative immunotherapies and emerging treatments in type 1 diabetes management by Malek Zarei, Mohammad Abbas Sheikholeslami, Masoud Mozaffari, Yassar Mortada

    Published 2025-01-01
    “…Beta cell therapies, including islet transplantation, offer promising outcomes but face challenges related to immunosuppression and donor availability. Stem cell therapies, particularly using mesenchymal stem cells (MSCs) and autologous hematopoietic stem cells (HSCs), demonstrate potential in immune modulation and beta cell regeneration. …”
    Get full text
    Article
  10. 350

    Health-Related Quality of Life after Pediatric Liver Transplantation: A Qualitative Analysis of the Perspectives of Health Care Providers by Mar Miserachs, David B. Nicholas, Anthony R. Otley, Vicky Lee Ng

    Published 2017-01-01
    “…HCP identified elements that both enhance (improved physical health, peer relationship, and activities of daily living) and challenge (need for immunosuppression, transplant follow-up, and restrictions) the multidimensional domains of HRQoL. …”
    Get full text
    Article
  11. 351

    Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy by V. E. Syutkin, V. P. Chulanov, I. V. Karandashova, V. A. Dolgin, A. O. Chugunov

    Published 2011-12-01
    “…Genotype C/C (rs12979860) was present in 6 (40%) patients with complete EVR and in none of slow-responders (one-sided p=0.041).The groups of recipients with and without complete EVR were comparable with sex, age, pre-treatment viral load, immunosuppression (cyclosporine vs. tacrolimus), weight and body mass index, and mean ribavirin dose. …”
    Get full text
    Article
  12. 352

    De Novo Onset of Myasthenia Gravis after Kidney Transplantation by Aaron de Souza, Rajesh Raj

    Published 2024-01-01
    “…This illness is surprising since immunosuppression after transplant is usually sufficient to prevent immune-mediated disease. …”
    Get full text
    Article
  13. 353

    Evaluation of CD4+ T Lymphocyte Counts to Predict Survival of ICU Patients with Sepsis Using Sepsis-3 Criteria: A Prospective Cohort Study by Guoge Huang, Xusheng Li, Chunmei Zhang, Haizhong Li, Mengling Jian, Chunyang Huang, Yingqin Zhang, Luhua Xian, Hongke Zeng, Yuanyuan Xia, Wenqiang Jiang

    Published 2024-01-01
    “…Sepsis remains a major health condition with a high mortality rate that may be related to immunosuppression. T lymphocyte subsets may reflect the immune function of sepsis patients. …”
    Get full text
    Article
  14. 354

    Feasibility and Safety of Bariatric Surgery in High-Risk Patients: A Single-Center Experience by Yusef Moulla, Orestis Lyros, Matthias Blüher, Philipp Simon, Arne Dietrich

    Published 2018-01-01
    “…., 2016) at least one of the following risk factors was met: age ≥ 70 years, body mass index (BMI) > 70 kg/m2, liver cirrhosis, end-organ failure, or immunosuppression by status after organ transplantation along with (Birkmeyer et al., 2010) at least two comorbidities associated with obesity. …”
    Get full text
    Article
  15. 355

    Modulatory Effects of Astragalus Polysaccharides on T-Cell Polarization in Mice with Polymicrobial Sepsis by Yu-Chen Hou, Jin-Ming Wu, Ming-Yang Wang, Ming-Hsun Wu, Kuen-Yuan Chen, Sung-Ling Yeh, Ming-Tsan Lin

    Published 2015-01-01
    “…Treatments with 100 and 200 mg APS/kg BW reduced Treg populations and elicited a more-balanced Th1/Th2 response that consequently attenuated immunosuppression in polymicrobial sepsis. High-dose APS administration led to excessive responses of Th17 cells which may have adverse effects in sepsis-induced organ injury.…”
    Get full text
    Article
  16. 356

    Severe Disabling Myalgia as an Initial Presentation of Polyarteritis Nodosa by H. M. Senarathna, C. L. Fonseka, H. A. S. Perera, P. U. T. De Silva, T. P. Weerarathna

    Published 2019-01-01
    “…With continuation of aggressive immunosuppression and rehabilitation for five months, the patient improved and was able to walk without support. …”
    Get full text
    Article
  17. 357

    Divergent Crosstalk Between Microglia and T Cells in Brain Cancers: Implications for Novel Therapeutic Strategies by Min-Hee Yi, Jinkyung Lee, Subin Moon, EunA So, Geonhyeok Bang, Kyung-Sub Moon, Kyung-Hwa Lee

    Published 2025-01-01
    “…The precise mechanisms underlying microglial interactions with T cells and their contributions to immunosuppression remain incompletely understood. <b>Methods</b>: This review comprehensively examines the complex cellular dialogue between microglia and T cells in two prominent brain malignancies: primary glioblastoma and secondary brain metastases. …”
    Get full text
    Article
  18. 358

    The Role of Gut Microbiota in Tumor Immunotherapy by Miao Wu, Jiawei Bai, Chengtai Ma, Jie Wei, Xianjin Du

    Published 2021-01-01
    “…Some bacteria help fight tumors by activating immunity, while some bacteria mediate immunosuppression to help cancer cells escape from the immune system. …”
    Get full text
    Article
  19. 359

    Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors. by Shirley D Wenker, María Isabel Farias, Victoria Gradaschi, Corina Garcia, Juan Beauquis, María Celeste Leal, Carina Ferrari, Xianmin Zeng, Fernando J Pitossi

    Published 2023-01-01
    “…We first observed that transplanted human dopaminergic precursors into the striatum of immunosuppressed rats elicited an early and sustained activation of astroglial and microglial cells after 15 days' post-transplant. …”
    Get full text
    Article
  20. 360

    A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy by F. A. K. Lodhi, T. Akcan, J. N. Mojarrab, S. Sajjad, R. Blonsky

    Published 2021-01-01
    “…Fetal safety should be considered and risks thoroughly discussed with the patient when choosing an immunosuppressive regimen for this condition.…”
    Get full text
    Article